Companies: 10,795·Total market cap: $144.5T
The Oncology Institute, Inc.

The Oncology Institute, Inc.

TOINASDAQHealthcare● Active
$5.22
+$0.35(+7.20%)
Market Cap$521970728
P/E Ratio
52W High$5.575
52W Low$2.015
Overview

The Oncology Institute, Inc. (TOI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TOI · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.35toi eps ttm · toi earnings per shareEarnings history
PE Ratio (TTM)toi pe ratio ttm · toi price to earningsPE Ratio deep dive
Revenue (TTM)$545.8Mtoi revenue ttm · toi annual revenueFull revenue history
Dividend YieldNo Dividenddoes toi pay dividends · toi dividend yieldDividend history
Shares Outstanding923.9Mtoi shares outstanding · toi floatShares outstanding history
Next EarningsAug 12, 2026Est.toi earnings date · toi next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$502.7M▲ +27.79% YoY
202320242025
the oncology institute, inc. revenue · toi revenue 2025
FY 2025Net Income-$60.6M▲ +6.27% YoY
202320242025
the oncology institute, inc. net income · toi profit 2025
FY 2025EPS$-0.54▲ +23.94% YoY
202320242025
toi eps · the oncology institute, inc. earnings per share 2025
TTM:Revenue: $545.8MNet Income: -$43.5MEPS: $-0.35View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis toi a buy · toi analyst rating
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$8.00Low
$5.22Current
$8.00Avg Target53.24% upside
$8.00High
toi price target · toi 12 month forecast

Total: 5 · Buy rate: 100.0%

The TOI analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +53.24% upside from the current price of $5.22.

Stock Performance

Full History
1D+6.37%
1W+13.85%
1M+29.50%
3M+86.33%
YTD+45.51%
1Y+99.23%
5Y-48.46%

About The Oncology Institute, Inc.

CEODaniel Virnich
IPO DateJun 4, 2020
Employees825
CountryUS

The Oncology Institute, Inc. an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial se…

what is the oncology institute, inc. · toi stock overview · the oncology institute, inc. company profile · who is the oncology institute, inc. ceo · toi NASDAQ · the oncology institute, inc. headquarters · the oncology institute, inc. business segments

About Stock Overview & Key Data

The Oncology Institute, Inc. (TOI) is a Healthcare company in the Medical - Care Facilities industry, listed on NASDAQ since Jun 4, 2020. As of the latest trading session, TOI stock price is $5.22, with a market capitalization of $517.9M. The stock has returned +99.23% over the past 12 months and +45.51% year-to-date.

According to 5 Wall Street analysts, the consensus rating for The Oncology Institute, Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2025, The Oncology Institute, Inc. reported revenue of $502.7M and net income of -$60.6M. For detailed data — including The Oncology Institute, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, The Oncology Institute, Inc. (TOI) stock price is $5.22. The stock is traded on NASDAQ under the ticker symbol TOI. The 52-week range is $2.02 – $5.58.

TOI stock priceTOI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice